In October, the U.S. government issued Axim Biotechnologies Inc a patent for a cannabis-based suppository to treat irritable bowel syndrome. Britain’s GW Pharmaceuticals Plc, which recently brought to market a drug derived from marijuana for epilepsy, is now seeking patent protection for another one...
The post Patents on pot? US lawsuit puts cannabis claims to the test appeared first on Raw Story.
CONTINUE READING >>>